SAMRIDH to invest Rs 2.45 Cr to Qure.ai
20 April 2022 | News
The financial assistance will help Qure.ai expand its artificial intelligence solution to screen for lung diseases across 15 states in India
The SAMRIDH Healthcare Blended Financing Facility, supported by the US Agency for International Development (USAID) and implemented by IPE Global, has committed Rs 2.45 crore to Qure.ai to scale artificial intelligence (AI)-enabled chest X-ray screening software, qXR, in 50 sites across more than 15 Indian states. The software will enable healthcare workers in the dual screening of COVID-19 and lung diseases such as tuberculosis, in remote and resource-challenged locations and will benefit an estimated 62,500 people in the next 12-14 months.
The partnership aims to advance its mission to scale market-based solutions and build sustainable and resilient healthcare systems for India.
